Nephros Inc
NASDAQ:NEPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
PagerDuty Inc
NYSE:PD
|
US |
|
Harvard Bioscience Inc
NASDAQ:HBIO
|
US |
|
O
|
Osmosun SA
PAR:ALWTR
|
FR |
|
PLC SpA
MIL:PLC
|
IT |
Wall St Price Targets
NEPH Price Targets Summary
Nephros Inc
According to Wall Street analysts, the average 1-year price target for NEPH is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NEPH's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for NEPH is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
What is the Revenue forecast for Nephros Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 2 years is 11%.
What is the Operating Income forecast for Nephros Inc?
Projected CAGR
18%
The compound annual growth rate for Operating Income over the next 2 years is 18%.
What is the Net Income forecast for Nephros Inc?
Projected CAGR
9%
The compound annual growth rate for Net Income over the next 2 years is 9%.
